Opioid agonist therapy (OAT)

OAT is a highly effective strategy to prevent hepatitis C, HIV, overdose and other drug-related harms. Medication such as methadone is prescribed to reduce or eliminate a person’s use of opioids, depending on their treatment goals.

Resources

Filter By

Guideline or manual

A guide to using extended-release buprenorphine (Sublocade®) in opioid agonist therapy (OAT)

Guideline or manual

Safer supply, opioid agonist treatment and harm rduction: National advocacy toolkit

Guideline or manual

Stimulant use disorder: Practice update

Research summary

Integrated care model for hepatitis C, HIV and substance use during the COVID-19 pandemic

Report

Early findings from safer supply pilot projects

Research summary

Supervised opioid use combined with housing and other services found to improve health outcomes for people who use drugs

Tool

Management of benzodiazepine use

Guideline or manual

Opioid agonist therapy (OAT)

Resources

Filter By

Filter By

Prescribed safer supply protocols: Fentanyl tablet

Prescribed safer supply protocols: Sufentanil

Imagine safe supply

Prescribed safer supply programs: Emerging evidence

A guide to using extended-release buprenorphine (Sublocade®) in opioid agonist therapy (OAT)

Safer supply, opioid agonist treatment and harm rduction: National advocacy toolkit

Stimulant use disorder: Practice update

Integrated care model for hepatitis C, HIV and substance use during the COVID-19 pandemic

Early findings from safer supply pilot projects

Supervised opioid use combined with housing and other services found to improve health outcomes for people who use drugs

Management of benzodiazepine use

Prescribed safer supply protocols: Fentanyl patch